Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus
- PMID: 2799652
Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus
Abstract
Barrett's esophagus is a common finding in patients with gastroesophageal reflux and is associated with a high incidence of serious complications (stricture, ulceration, and carcinoma). The reason that only a portion of patients with reflux develop Barrett's esophagus and why some are prone to develop complications is unknown. Twenty-three patients with Barrett's esophagus underwent endoscopy, 24-hour esophageal pH monitoring, and manometry. Nine of these patients with gastritis underwent 24-hour gastric pH monitoring, and three with symptoms of duodenogastric reflux underwent 99mTc-labeled hepato-iminodiacetic acid scanning. Patients with complicated (n = 12) and uncomplicated (n = 11) Barrett's esophagus were compared with each other and with patients with reflux esophagitis (n = 53) and normal volunteers (n = 50). Patients with Barrett's esophagus showed an increased exposure to acid and alkaline gastric juice compared with patients with esophagitis and normal volunteers. In the patients with Barrett's esophagus with and without complications, there was no significant difference in age, incidence of defective lower esophageal sphincter, incidence of defective peristalsis, extent of the Barrett's epithelium, or percent time the esophageal pH was less than 4. In contrast, the percent time the esophageal pH was greater than 7 was significantly greater in patients with complications. This alkaline exposure is likely to be related to duodenogastric reflux. This was supported by positive gastric pH scores for duodenogastric reflux and 99mTc-labeled hepato-iminodiacetic acid scans in patients with Barrett's complications. These findings suggest that the development of complications in Barrett's esophagus is the result of the damaging effect of refluxed duodenal juice.
Similar articles
-
[Barrett's esophagus, gastroesophageal acid reflux and duodenogastric reflux during the digestive and postprandial period].Gastroenterol Clin Biol. 1992;16(12):978-83. Gastroenterol Clin Biol. 1992. PMID: 1493899 French.
-
Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux.Ann Surg. 1992 Jul;216(1):35-43. doi: 10.1097/00000658-199207000-00006. Ann Surg. 1992. PMID: 1632700 Free PMC article.
-
Characterization of acid and alkaline reflux in patients with Barrett's esophagus. G.O.S.P.E. Operative Group for the study of Esophageal Precancer.Dis Esophagus. 1997 Jan;10(1):16-22; discussion 22-3. Dis Esophagus. 1997. PMID: 9079268
-
Management of Barrett's esophagus free of dysplasia.Semin Thorac Cardiovasc Surg. 1997 Jul;9(3):279-84. Semin Thorac Cardiovasc Surg. 1997. PMID: 9263346 Review.
-
[Diagnosis of gastroesophageal reflux and Barrett esophagus].Zentralbl Chir. 2000;125(5):414-23. Zentralbl Chir. 2000. PMID: 10929625 Review. German.
Cited by
-
Barrett's esophagus: environmental influences in the progression of dysplasia.World J Surg. 2003 Sep;27(9):1014-7. doi: 10.1007/s00268-003-7054-0. Epub 2003 Jul 28. World J Surg. 2003. PMID: 12879287 Review.
-
A new physiologic approach for the surgical treatment of patients with Barrett's esophagus: technical considerations and results in 65 patients.Ann Surg. 1997 Aug;226(2):123-33. doi: 10.1097/00000658-199708000-00002. Ann Surg. 1997. PMID: 9296504 Free PMC article. Clinical Trial.
-
Medical treatment of gastroesophageal reflux disease does not prevent the development of Barrett's metaplasia and poor esophageal body motility.Langenbecks Arch Chir. 1997;382(2):95-9. doi: 10.1007/BF02465096. Langenbecks Arch Chir. 1997. PMID: 9128874
-
Duodenogastric reflux in patients with Barrett's esophagus.Dig Dis Sci. 1990 Jun;35(6):759-62. doi: 10.1007/BF01540180. Dig Dis Sci. 1990. PMID: 2344809
-
Effect of body mass index on adenocarcinoma of gastric cardia.World J Gastroenterol. 2003 Dec;9(12):2658-61. doi: 10.3748/wjg.v9.i12.2658. World J Gastroenterol. 2003. PMID: 14669307 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical